Vaccine Technologies: US FDA Isn’t Afraid Of Needle-Free Delivery, But It Takes Time To Develop, Woodcock Says

 
• By Derrick Gingery

The agency is interested in alternative formulations for COVID-19 inoculations, but pushed the traditional injection presentation because it was easier to develop quickly.

Nasal COVID-19 vaccine formulation
A nasal COVID-19 vaccine formulation is one of several new technologies under consideration, Acting FDA Commissioner Janet Woodcock said. • Source: Alamy

More from Vaccines

More from Pink Sheet